genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2024
Dementia
Genome Editing
Epigenetic Editor CHARMs Prion Disease
Drug Discovery
Potential Sanfilippo Syndrome Treatment, Anakinra, Shows Promise in Clinical Trial
News
Neurodegenerative Disease Linked to FUS Protein Aggregates’ Prion-like Mechanism
Featured
Alzheimer’s Disease Neurons Reenter Cell Cycle, Become Senescent
News
New Theory on Parkinson’s Origins and Spread
Drug Discovery
Alzheimer’s Tauopathy Model Uses Human Neurons, Implicates UFMylation
Drug Discovery
TBI’s Link to Long-Term Damage Could Be Broken by Targeting Key Protein
Featured
Alzheimer’s Risk Linked to Brief, Localized Oxygen Deficits in Brain
News
Novel Target for Alzheimer’s Disease Identified
News
Protein Mapping Yields New Insights into the Aging Brain
1
2
3
...
20
Page 2 of 20
Scroll Up
Scroll Up
